Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 885-906, October 2007

Comorbidities in rheumatoid arthritis

  • Kaleb Michaud, PhD (Assistant Professor of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198-6270, USA. Tel.: +1 40 559 7239; Fax: +1 402 559 2466.

University of Nebraska Medical Center, Omaha, USA

National Data Bank for Rheumatic Diseases, Wichita, USA

University of Kansas School of Medicine, Wichita, USA

National Data Bank for Rheumatic Diseases, Wichita, USA

Rheumatoid arthritis (RA) is often characterized by the burden of swollen joints, pain, and decreased physical function, but less understood are the many manifestations of additional health conditions that are associated with RA and its treatments. First brought to light with observations of increased mortality in RA, studies noted the increased rates of cardiovascular and infection events. The chronic, debilitating, autoimmune nature of RA affects the patient directly or indirectly in almost all organ systems, from cardiovascular problems and infections to depression and gastrointestinal ulcers. On average, the established RA patient has two or more comorbid conditions. It should be the responsibility of the rheumatologist to take these and the risk of additional conditions into account when treating the patient. This chapter reviews important comorbidities in patients with RA, their prevalence, and their relation to RA.

Key words: anti-TNF therapy, cardiovascular disease, comorbid condition, comorbidity index, comorbidity, infection, malignancy, outcomes, rheumatoid arthritis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6942(07)00076-9

doi:10.1016/j.berh.2007.06.002

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 5 , Pages 885-906, October 2007